{
    "medicine_id": "74a0840a8e7541200c8fcd765a6766fa938c38ee",
    "platform_id": "DB06810",
    "metadata": {
        "name": "Mozobil 24 mg 1 2mL Solution",
        "composition": "24 mg 1 2mL Plicamycin",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of testicular cancer as well as hypercalcemia and hypercalciuria associated with a variety of advanced forms of cancer",
            "contraindications": {
                "disease": "The most important form of toxicity associated with the use of plicamycin consists of a dose related bleeding syndrome which usually begins with an episode of epistaxis Plicamycin crosses the blood brain barrier the concentration found in brain tissue is low but it persists longer than in other tissues",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Plicamycin is lethal to Hela cells in 48 hours at concentrations as low as 0 5 micrograms per milliliter of tissue culture medium Plicamycin has shown significant anti tumor activity against experimental leukemia in mice when administered intraperitoneally",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of cardiotoxicity can be increased when Margetuximab is combined with Plicamycin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}